Home > News > Immunicon Announces Agreements with R&D Systems
August 19th, 2003
Immunicon Announces Agreements with R&D Systems
Abstract:
Immunicon Corporation today announced the completion of a non-exclusive license and supply agreement with R&D Systems, Inc. of Minneapolis, MN. In addition, under the terms of a separate agreement, R&D Systems, a wholly-owned subsidiary of Techne Corporation made an equity investment in Immunicon. Under the license and supply agreement, R&D Systems will use Immunicon's magnetic nano-particle cell isolation technology in conjunction with their reagents to develop products for life science research. (PDF)
Source:
PRNewswire
Bookmark:
| Related News Press |
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||